Early versus periprocedural administration of abciximab for primary angioplasty: A pooled analysis of 6 studies

Early administration of abciximab improves epicardial patency (TIMI flow) before PCI and results in better myocardial tissue perfusion (ST-resolution) after the procedure. The promising effects on clinical outcomes need to be tested in larger studies.